Print ArticleCreated as an alternate route of drug administration to improve patient compliance and reduce drug side effects, prescription skin patches are rapidly becoming an important healthcare product category. While quietly gaining market share for the treatment of chronic conditions such as angina, hypertension and HRT, the technology is set to make further inroads as transdermal patches for a host of new conditions wind their way through the development and clinical trial process.
Growth in demand for prescription drug patches is being driven by several factors – factors with strong demographic and population trend underpinnings. Technology has also played a major role in prescription patch growth. Advances in synthetic materials and patch design have led to patches that are more esthetically acceptable and that are capable of delivering sustained dosing of active compounds for several days in a smaller package. “The number of drug therapies being developed in patch form is expanding,” explains George Perros, Greystone Managing Director. “At the same time, improvements in patch esthetics and the success of existing prescription patches have increased consumer market acceptance.”
Source : www.greystoneassociates.org
Mail to a Friend
Link to this article
